Access cutting-edge alzheimer's disease treatment through this clinical trial at a research site in Sherman Oaks. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Sherman Oaks location
Access alzheimer's disease specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related alzheimer's disease treatment provided free
Check if you qualify for this alzheimer's disease clinical trial in Sherman Oaks, CA
No-Cost Study Care
Local to Sherman Oaks
Convenient for CA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The main purpose of this study is to look at how safe the study drug (mevidalen) is and whether it works to alleviate symptoms when given to people with mild to moderate Alzheimer Disease (AD) dementia. This is done by looking at participants: thinking and memory (cognition), everyday activities and sleep, AD symptoms, physical activity, irritability or anxiety. The study is expected to last approximately 26 weeks and may include up to 14 visits.
Sponsor: Eli Lilly and Company
Yes, this clinical trial (NCT06538116) has an active research site in Sherman Oaks, CA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for alzheimer's disease treatment options in Sherman Oaks, CA, this clinical trial (NCT06538116) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Sherman Oaks research site is actively enrolling participants for this clinical trial. You'll receive care from experienced alzheimer's disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all alzheimer's disease clinical trials near you to find additional studies recruiting in your area.
See all alzheimers disease clinical trials recruiting in Sherman Oaks — not just this study.
Browse Alzheimers Disease Trials in Sherman Oaks →